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ABSTRACT
The extracellular matrix is composed of a three-dimensional ﬁber mesh ﬁlled with different macromolecules such as:
collagen (mainly type I and III), elastin, glycosaminoglycans, and proteoglycans. In the lung, the extracellular matrix
has several functions which provide: 1) mechanical tensile and compressive strength and elasticity, 2) low mechanical
tissue compliance contributing to the maintenance of normal interstitial ﬂuid dynamics, 3) low resistive pathway for
an effective gas exchange, d) control of cell behavior by the binding of growth factors, chemokines, cytokines and
the interaction with cell-surface receptors, and e) tissue repair and remodeling. Fragmentation and disorganization of
extracellular matrix components comprises the protective role of the extracellular matrix, leading to interstitial and
eventually severe lung edema. Thus, once conditions of increased microvascular ﬁltration are established, matrix
remodeling proceeds fairly rapidly due to the activation of proteases. Conversely, a massive matrix deposition of
collagen ﬁber decreases interstitial compliance and therefore makes the tissue safety factor stronger. As a result,
changes in lung extracellular matrix signiﬁcantly affect edema formation and distribution in the lung.
Key words: collagen, glycosaminoglycans, proteoglycan, interstitial pressure.
INTRODUCTION
The Extracellular Matrix (ECM) represents the three-
dimensional scaffold of the alveolar wall, which is com-
posed of a layer of epithelial and endothelial cells, their
basement membrane and a thin layer of interstitial space
lying between the capillary endothelium and the alveolar
epithelium (West and Mathieu-Costello 1999).
In the segment where the epithelial and endothe-
lial basement membranes are not fused, the interstitium
is composed of cells, the ﬂuid phase of the ECM and a
macromolecular ﬁbrous component. This ﬁbrous mesh
consists mainly of collagen types I and III, which provide
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tensile strength, elastin conveying elastic recoil (Rocco
et al. 2001, 2003), and glycosaminoglycans (GAGs), the
major components of the non-ﬁbrillar interstitium com-
partment (Negrini et al. 2003, Souza-Fernandes et al.
2006). In the lung, the ECM plays several roles which
provide: a) mechanical tensile and compressive strength
and elasticity; b) low mechanical tissue compliance con-
tributing to the maintenance of normal interstitial ﬂuid
dynamics (Miserocchi et al. 1993); c) low resistive path-
way for an effective gas exchange, d) control of cell be-
havior by the binding of growth factors, chemokines,
cytokines and the interaction with cell-surface receptors
(Johnson et al. 2005), and e) tissue repair and remod-
eling. Although many functions of ECM are very well
described (Roberts et al. 1997, Noble and Jiang 2006)
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the role of ECM components on the maintenance of in-
terstitial ﬂuid volume needs to be better clariﬁed.
In this review, we will discuss the ECM organiza-
tion and the relationship between ECM and lung edema.
THE EXTRACELLULAR MATRIX ORGANIZATION
The ECM consists of ﬁbrous proteins (collagen and elas-
tin) and structural or adhesive proteins (ﬁbronectin and
laminin) embedded in a hydrated polysaccharide gel con-
taining several glycosaminoglycans.
COLLAGEN
Collagen ﬁbers constitute the main component of the
ECM and are a ﬁbrous protein that consists of three α-
chains, which form a rope-like triple helix, providing ten-
sile strength to the ECM (Montes 1996). Despite their
broad diversity in the connective tissue, types I, II, III
(ﬁbrillar) and IV, V, VI (non ﬁbrillar or amorphous) rep-
resent the main collagen ﬁbers. Type III collagen ﬁber
is more ﬂexible and susceptible to breakdown, type I
collagen is comprised of thicker more cross-linked ﬁb-
ril (Rocco et al. 2001, Santos et al. 2006), whereas type
IV collagen ﬁber is located mainly in basement mem-
brane. Their turnover is a dynamic process, necessary to
the maintenance of the normal lung architecture (Rocco
et al. 2003). The ﬁnal collagen accumulation does not
depend only on its synthesis, but also, on its degradation
(Rocco et al. 2001, 2003). Consequently, the ECM is
a dynamic structure, and equilibrium between synthesis
and degradation of ECM components is required for the
maintenance of its homeostasis (Santos et al. 2006).
ELASTIN
Elastic ﬁbers represent another constituent of the ECM
and comprise three components deﬁned according to
their amount of elastin and ﬁbril orientation: 1) oxytalan
ﬁber composed of a bundle of microﬁbrils, 2) elaunin
ﬁbers made up of microﬁbrils and a small amount of
elastin, and 3) fully developed elastic ﬁbers consisting of
microﬁbrils and abundant elastin (Montes 1996). Many
types of cells, including condroblasts, myoﬁbroblasts,
and smooth muscle cells synthesize these ﬁbers. Due to
their mechanical properties, elastic ﬁbers provide recoil
tension to restore the parenchyma to its previous conﬁgu-
ration after stimulus for inspiration has ceased. In normal
alveolar septa, a subepithelial layer of elastic ﬁbers com-
posed mainly of fully developed elastic ﬁbers, confers
a great elasticity to the alveolar tissue in normal situa-
tions (Mercer and Crapo 1990). Elastosis, as determined
by septal inﬂammation and ﬁber fragmentation, leads to
derangement of the alveolar wall architecture (Negri et
al. 2000, Rocco et al. 2003). In response to increased
tissue destruction, reactivation of elastin synthesis is ob-
served, resulting in signiﬁcant changes in themechanical
properties of the lung (Rocco et al. 2001).
GLYCOSAMINOGLYCANS AND PROTEOGLYCANS
In the connective tissue, proteoglycans (PGs) form a
gelatinous and hydrated substance embedding the ﬁb-
rous proteins. Proteoglycans are constituted of a central
protein bound to one or more polysaccharides, denomi-
nated glycosaminoglycans (GAGs).
GLYCOSAMINOGLYCANS
GAGs are long, linear, and heterogeneous polysaccha-
rides, which consist of repeating disaccharide units.
There are two main types of GAGs: 1) Non-sulfated
GAG (hyaluronic acid) and 2) Sulfated GAGs (heparan
sulfate and heparin, chondroitin sulfate, dermatan sul-
fate, and keratan sulfate). With the exception of hyalu-
ronic acid, GAGs are usually covalently attached to a
protein core, forming an overall structure referred to as
proteoglycans (Souza-Fernandes et al. 2006).
Non sulfated glycosaminoglycan: hyaluronic acid
Hyaluronic acid is the most abundant and the largest
non-sulfated GAG in the ECM. It is primarily synthe-
sized by mesenchymal cells, being a necessary molecule
for the assembly of a connective tissue matrix and an
important stabilizing constituent of the loose connective
tissue. It also participates in tissue hydration (Tammi et
al. 2002), and is involved in several other functions, such
as tissue repair (Li et al. 2000), and protection against
infections and proteolytic granulocyte enzymes (Cantor
et al. 2000).
Sulfated glycosaminoglycans
These other GAGs are synthesized intracellularly, sul-
fated, secreted, and usually covalently bound into pro-
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teoglycans. The polyanionic nature of GAGs is the main
determinant of the physical properties of PGs molecules,
allowing them to resist compressive forces and to si-
multaneously maintain tissue hydration. They are much
smaller than HA, usually only 20 to 200 sugar residues
long (Souza-Fernandes et al. 2006).
Within the lung parenchyma, themost abundant sul-
fated GAG is heparan sulfate, a polysaccharide that is ex-
pressed in virtually every cell in the body and comprises
50% to 90% of the total endothelial PGs (Whitelock and
Iozzo 2005). Although it is initially produced in a cell-
surface-bound form, it can also be shed as a solubleGAG.
The mechanism of action of heparan sulfate includes a
speciﬁc and non-covalent interaction with various pro-
teins which affects the topographical destination, half-
life, and bioactivity of the protein. Furthermore, hep-
aran sulfate acts on morphogenesis, development, and
organogenesis (Whitelock and Iozzo 2005). Heparan
sulfate is also involved in a variety of biological pro-
cesses including cell-matrix interactions and activation
of chemokines, enzymes, and growth factors (Whitelock
and Iozzo 2005).
Heparin is the most highly modiﬁed form of hep-
aran sulfate. This GAG, which can be considered an
oversulfated intracellular variant of the heparan sulfate,
is commonly used in patients as an anticoagulant drug
(Whitelock and Iozzo 2005). Heparin and heparan sul-
fate are very closely related and may share many struc-
tural and functional activities. The lung is a rich na-
tive source of heparin. Heparin’s abundance may be ex-
plained by the fact that the lung is rich in mast cells,
which may be heparin’s sole original cell. Mast cell hep-
arin resides in secretory granules, wheremost of theGAG
chains are linked to a core protein (serglycin), forming
macromolecular PGs much larger than commercial hep-
arin. Very little heparin is incorporated into cell surface
PG of epithelial and endothelial cells that are more likely
to contain heparan sulfate, which in turn is under-sulfated
compared with heparin. Some heparan sulfate chains
of vascular endothelium contain short heparin-like se-
quences. However, most native lung heparin is locked
up in mast cells as large PGs. This does not necessarily
mean that heparin’s physiological action occurs exclu-
sively within cells, because stimulated mast cells secrete
heparin outside the cell along with granule-associated
mediators, such as histamine, chymase, and tryptase
(Ruoss et al. 1991).
PROTEOGLYCANS
In the lung, the main PGs families may be distinguished
based on GAGs composition, molecular weight, and
function: chondroitin sulfate-containing PG (CS-PG:
Versican), heparan sulfate-containing PGs (HS-PGs:
Perlecan andGlypican), chondroitin and heparan sulfate-
containing PGs (CS-HS-PGs: Syndecan), and dermatan-
sulfate-containing PGs (DS-PG: Decorin). They are lo-
calized in different areas of the extracellular matrix: ver-
sican in the pulmonary interstitium, perlecan in the vas-
cular basement membrane, decorin in the interstitium
and in the epithelial basementmembrane linkedwith col-
lagen ﬁbrils, syndecan and glypican in the cell surface
(Roberts et al. 1997).
Versican is a large molecule found around lung ﬁ-
broblasts and blood vessels in regions not occupied by
collagen and elastin (Roberts et al. 1997). The precise
function of versican is unclear but it is thought to be in-
volved in tissue hydration in mature tissues. It may form
aggregates with hyaluronic acid, ﬁbronectin and various
collagens, playing an important role in cell to matrix in-
teraction. Versican has been shown to link with smooth
muscle cells in the walls of airways and lung vessels, in-
hibiting cell-matrix adhesion (Iozzo andMurdoch 1996),
regulating mesenchymal cells differentiation and, stim-
ulating matrix synthesis, favoring wound healing.
Perlecan is the largest PG in the lung and is a typical
component of vascular basement membrane (Yurchenko
and Schittny 1990), although it has also been identiﬁed
within the ECM of some tissues, remote from basement
membrane. Certainly its complex core protein provides
the potential to interact with numerous proteins. In the
basement membranes it provides a ﬁltration barrier inter-
acting with collagen IV limiting ﬂow of macromolecules
or cells between two tissue compartments. It also regu-
lates the interaction of the basic ﬁbroblast growth factors
with their receptors and modulates tissue metabolism.
Syndecan and glypican are converselymore densely
arranged in the cell surface (Zhao et al. 1999). Sinde-
can´s function is commonly associated with its heparan
sulfate chains playing a relevant role in wound healing
(Tumova et al. 2000).
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Decorin is the smallest dermatan-sulfate-containing
PGs. The presence of decorin alters the kinetics of ﬁbril
formation and the diameter of the resultingﬁbril (Roberts
et al. 1997) modulating tissue remodeling. Indeed, its
namewas derived from its surface decoration of collagen
ﬁbrils when viewed in the electron microscope.
These data indicate that the function of PGs and
GAGs in the lung is not limited to the maintenance of
the mechanical and ﬂuid dynamic properties of the par-
enchyma. These molecules are also important in tissue
development and recovery after injury, interacting with
inﬂammatory cells, proteases, and growth factors. Thus,
the ECM transmits essential information to pulmonary
cells, regulating their proliferation, differentiation, and
organization. The structural integrity of the pulmonary
interstitium largely depends on the balance between
the regulation of synthesis and degradation of ECM
components.
EXTRACELLULAR MATRIX METALLOPROTEASIS
Although many proteases are able to cleave ECM mo-
lecules, the family of Zn++ matrix metalloproteinases
(MMPs) and their inhibitors are likely to be the normal
physiologically relevant mediators of ECM degradation
(Lanchou et al. 2003, Elkington and Friedland 2006,
Greenlee et al. 2007). They can degrade many proteins
including collagens, ﬁbronectin, laminin, proteoglycans,
entactins, and elastin. In particular, they are very impor-
tant in: a) the breakdown of ECM and basement mem-
brane, b) tissue remodeling and angiogenesis, and c) the
restoration of functional connective tissue in the wound-
healing process.
Gelatinases (MMP-2 andMMP-9) are the subgroup
of MMPs most extensively studied in human intersti-
tial lung diseases and in experimental models of lung
ﬁbrosis, probably due to the facility and great sensitivity
of revealing gelatinolytic activity through gelatin zymo-
grams. Both gelatinases contain ﬁbronectin type II-like
repeatswithin their catalytic domain, resulting in a higher
binding afﬁnity to gelatin and elastin. The MMP-2 is
produced by ﬁbroblasts, endothelial and epithelial cells,
and macrophages. MMP-2 (gelatinase A) is known to
be effective primarily against type IV collagen and other
basement-membrane components although a weak abil-
ity to degrade stromal collagens has been also reported.
On the contrary MMP-9 (gelatinase B) is not produced
by resident cells, but under various forms of stimula-
tion bronchial epithelial cells, ciliar cells, alveolar type
II cells, ﬁbroblasts, smooth muscle cells, and endothelial
cells may produce MMP-9. Alveolar type I, neuroen-
docrine, and goblet cells have not yet been shown to
produce MMP-9. Leukocytes in the lung can also be
a source of MMP-9. Macrophages, eosinophils, mast
cells, lymphocytes, and dendritic cells all can produce
MMP-9.
Because MMPs may cause signiﬁcant host dam-
age, their proteolytic activity is tightly regulated. Thus,
MMPs are rarely stored, but require gene transcription
before secretion, with the exception of neutrophil MMP-
8 and -9. In fact, these are either secreted as pro-enzymes
that require proteolytic cleavage or are activated intra-
cellularly by pro-protein convertases such as furin. Spe-
ciﬁc inhibitors of MMPs – the tissue inhibitors of met-
alloproteinases (TIMPs) – which bind MMPs in a 1:1
manner are secreted to prevent enzymatic activity; as a
result the balance betweenMMPs and TIMPs determines
matrix turnover, where either an excess of MMPs or a
deﬁcit of TIMPs may result in excess ECM degradation
(Elkington and Friedland 2006).
The majority of MMPs are not expressed in nor-
mal healthy tissues, but are expressed in diseased tis-
sues, that are inﬂamed or undergoing repair and remod-
eling (Lanchou et al. 2003). MMP expression may be
upregulated by exogenous stimuli, cytokines, and cell-
cell contact. Conversely, cytokines such as interferon
(IFN)-γ and interleukins (IL)-4 and -10 may down reg-
ulate MMP expression. Both inﬂammatory and stromal
cells can express MMPs, although the proﬁle is both cell
and stimulus speciﬁc.
THE EXTRACELLULAR MATRIX AND
THE BASAL MEMBRANE
The basal lamina of pulmonary cells is extremely com-
plex and it is composed of different molecules like la-
minin, nidogen, and perlecan (Fig. 1) (Furuyama and
Mochitate 2000).
1) Laminin is a 100 nm long sword-shaped trimmer
which self-assembles into a feltlike sheet with the
help of its beta/gamma arms (Jones et al. 2005).
Laminins are important in linking the cells to their
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basement membranes. The ‘sword’ tips can bind
cell receptors, and the crosspieces allow laminin to
bind to other laminin molecules. Other sites for
nidogen and perlecan binding are also present in
the molecule;
2) Nidogen, also known as entactin, is a dumbbell
shaped 150 kDa sulfated glycoprotein, with three
domains. Nidogen connects laminin to both the col-
lagen layers and perlecan in the basal lamina;
3) Perlecan, which has a 400 kDa core protein with
three heparan sulfate chains attached, is the pre-
dominant proteoglycan in the basal lamina. It binds
to collagen, laminin, nidogen, and other perlecan
molecules (Nguyen et al. 2002).
On one side of the cell membrane, the basal lamina
is linked to the cell by means of integrins (Tschumper-
lin et al. 2004, Ingber 2006,), while on the other side it
is liked to the ECM through links to collagen type IV.
Integrins are adhesive membrane receptors that exist as
heterodimers. They exhibit a “Velcro” effect: i.e. they
have strength in numbers, but are individually easy to
disrupt. They require Ca++ or Mg++ to bind, and their
job is to link the ECM to the cytoskeleton. Fibronectin
reinforces the connections between the basal laminawith
both the cell membrane and the other ECM components.
It is likely that type IV collagen is chieﬂy responsible for
the great tensile strength of the ECM and that the other
molecules play important roles in consolidating the struc-
ture of the ECM and its connections with overlying cells.
PULMONARY INTERSTITIAL FLUID DYNAMICS
The interstitial compartment of the lung is kept at a sub-
atmospheric pressure in physiological conditions, with a
low amount of extravascular water. In the lung, a rela-
tively “dry” interstitial space allows a minimum thick-
ness of the air-blood barrier to optimize gas diffusion.
A rise in extravascular lung water may occur because of
an increase in the pressure gradient across the microvas-
cular barrier and/or by an increase in perm-porosity of
the endothelial barrier.
The maintenance of the steady state interstitial ﬂuid
turnover results from the balance between several fac-
tors, such as: 1) the transendothelial ﬂuid and solutes
ﬁltration, 2) the convective outﬂows into the lymphatic
system, and 3) the mechanical and hydrophilic prop-
erties of the solid elements of the ECM. The hydraulic
pressure of the free liquid phase of the pulmonary inters-
titium (Pi ) reﬂects the dynamic situation that results
from the complex interaction between the factors stated
above representing a key variable to understand the
mechanisms which control lung ﬂuid balance (Miseroc-
chi et al. 1990, 1997, Negrini et al. 2003). The end-
expiratory Pi is signiﬁcantly lower than intra-pleural
(Pliq) and extra-pleural (Pepl) liquid pressure, indicat-
ing that the lung parenchyma is relatively “dehydrated”
compared to the other two tissue compartments (Fig. 2).
The Pi distribution is not uniform within the lung paren-
chyma, decreasing by ∼ 0.7 cmH2O/cm of lung height.
The gravity – dependent Pi distribution reﬂects: a) the
uneven mechanical stress developing in lung tissue at
various lung heights, b) the inhomogeneous perfusion
of the lung parenchyma, in analogy with that found in
the pleural space, and c) the greater drainage of intersti-
tial ﬂuid into the lymphatic system in the lower regions.
During inspiration, sustained by lowered pleural surface
pressure, both Pliq and Pi become more subatmospheric
(Miserocchi et al. 1990, Miserocchi and Negrini 1997,
Negrini et al. 2003).
The ﬂuid bulk ﬂow (Jv) between the pulmonary
capillaries (c) and the surrounding interstitium (i) is de-
scribed by the well-known Starling law:
Jv = L p · S · [(Pc − Pi )− σ(πc − πi )] (1)
where P e π are the hydraulic and colloidosmotic pres-
sures in the two compartments, L p is the hydraulic ﬁl-
tration coefﬁcient of the pulmonary capillary endothelial
layer, S is the exchange surface area and σ is the reﬂec-
tion coefﬁcient of the endothelium for total proteins, a
correction factor accounting for the protein to endothe-
lial pore radii ratio. The factor in the square parenthe-
sis gives the net pressure gradient across the membrane,
1Pnet .
THE EXTRACELLULAR MATRIX AND LUNG EDEMA
Figure 3 shows examples of hydraulic (P) and colloi-
dosmotic (π) pressures from the pulmonary capillaries
(c) and surrounding interstitial space (i) under normal
condition, mild or severe interstitial edema. While Pi is
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Fig. 1 – Links among the cell membrane, the basal lamina, and the extracellular matrix.
very negative in normal lungs, ensuring the maintenance
of a net ﬂuid ﬁltration into the interstitial space, the early
phase of interstitial edema is associated to an increase in
Pi with no signiﬁcant change in interstitial ﬂuid volume.
This phenomenon is caused by the low tissue compli-
ance, provided by the tight structure of the ﬁbrous ma-
trix, and represents an important “tissue safety factor”
to counteract further progression of pulmonary edema.
With the worsening of the edema, Pi drops back to zero
and subsequently remains unchanged despite a marked
increase in the wet-to-dry weight ratio of the lung. The
worsening of edema occurs because of an increasingly
high ﬁltration rate, in spite of a progressive augment in
Pi and thus a reduced 1Pnet . Hence, at least two fac-
tors interact to determine the development of pulmonary
edema: 1) the loss of the tissue safety factor, which re-
ﬂects in an increase of tissue compliance and 2) a rise in
microvascular permeability (Passi et al. 1998).
EFFECTS OF HYDRAULIC AND LESIONAL EDEMA ON
ECM COMPONENTS
Interstitial lung edema led to some degree of disorgan-
ization of the extracellular matrix, despite its strong me-
chanical resistance, particularly at the expense of pro-
teoglycans (Negrini et al. 2003). These molecules are
responsible for the structural integrity of pulmonary in-
terstitium as they control ﬂuid dynamics through their
inﬂuence on microvascular permeability and tissue com-
pliance. They also are involved in cell-cell and cell-
matrix interactions and in the cytokine network since
they regulate the trafﬁc of the molecules within the in-
terstitial space and promote interactions (Roberts et al.
1997). To better understand the relationship between
pulmonary interstitial pressure and the functional state
of the matrix, hydraulic and lesional edema were devel-
oped in anesthetized rabbits by intravenous injection of
saline solution (0.5 ml · min-1 · kg-1) (Miserocchi et al.
1993) and a single bolus of pancreatic elastase (200µg,
7 IU) (Negrini et al. 1998), respectively.
In hydraulic edema the biochemical analysis of tis-
sue structure reveals an initial fragmentation of chon-
droitin sulfate proteoglycan due to mechanical stress
and/or proteolysis. On the other hand, in lesional edema,
there is a partial fragmentation of heparan sulfate proteo-
glycan because of enzymatic activity. The fragmentation
of proteoglycans is probably induced by increased ex-
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Fig. 2 – Schematic representation of transpleural liquid ﬂows (arrows) under physiological conditions.
Mesothelial cells and adjoining interstitium, with embedded capillaries and lymphatics are shown. At the
top, themesothelial cell depicts the cell mechanisms involved in pleural liquid turnover [microvilli, vesicles,
electrolyte transporters (grey circles)]. Arrow size is proportional to the corresponding ﬂow magnitude.
Hydraulic (P) and colloidosmotic (π) pressures (cmH2O) are involved in the Starling balance. Pepl
(extrapleural interstitial pressure), Pliq (intrapleural pressure) and Pi (lung interstitial pressure).
Fig. 3 – Hydraulic (P) and colloidosmotic (π) pressures of the microvasculature (cap) and surrounding
interstitial space (int) under normal condition, during mild, and severe interstitial edema. Grey arrow
represents transendothelial ﬂow while black arrow represents trans-lymphatic ﬂow. Hydraulic (P) and
colloidosmotic (π) pressures are shown as cmH2O.
travascular water yielding tissue stress and weakness of
PGs non-covalent bands with other matrix molecules or
tissue metalloproteinases activation (Passi et al. 1999).
Therefore, the fragmentation of chondroitin sulfate
proteoglycan yielded a marked increase in tissue com-
pliance and a loss in tissue safety factor, while hep-
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aran sulfate proteoglycan lesion led to an augment in
microvascular permeability (Negrini et al. 1998). Early
in the course of hydraulic edema there was an increase
in MMP-2, while in lesional edema both MMP-2 and
MMP-9 were augmented (Passi et al. 1998).
Contrary to hydraulic edema, hypoxic pulmonary
edema led to fragmentation of intermediate molecular
weight heparin-sulfate PGs, such as perlecan of the base-
ment membrane (Miserocchi et al. 2001b).
Recent data also suggest that the integrity of the
heparan-sulfate proteoglycan components of the pulmo-
nary ECM is required to maintain the three-dimensional
architecture of the matrix itself, which in turn, ensures
its mechanical response to increased ﬂuid ﬁltration (Ne-
grini et al. 2006).
In an experimental model of ﬁbrosis there was a
marked reduction in the absolute volume of edema, in
parallel with a reduction in lung volume, suggesting that
ﬁbrosis deeply affects the distribution of edema in the
lung (Zwinkler et al. 1994).
EXTRACELLULAR MATRIX AND CELL PLASMA
MEMBRANE
The response of epithelial cells to basement membrane
deformation is affected by the extracellular matrix,
plasma membrane, and cell cytoskeleton. Proteins that
link the extracellular matrix with stress bearing cytos-
keletal biopolymers play a pivotal role in mechanosens-
ing and transduction (Geiger et al. 2001). They are as-
sembled in so-called focal adhesion sites, plaques, or
complexes. Focal adhesions are highly plastic structures
and remodel in a force-dependent manner (Coppolino
and Dedhar 2000). This allows adherent cells to probe
the regional impedance of the surrounding scaffolding
and, in turn, provides cues for directional control of
locomotion and cell shape (Geiger et al. 2001). The
most extensively studied adhesion receptors involved
in mechanotransduction are the integrins. After ligand-
induced activation, integrins transduce matrix-depend-
ent intracellular biochemical signals. Other adhesion
molecules such as cadherins are also increasingly recog-
nized as playing important roles in mechanotransduction
and as molecular targets of deformation induced impair-
ments of the epithelial and endothelial barrier function
(Cavanaugh et al. 2001).
The relationship between the ECM and plasma
membrane has important implications in preventing lung
injury. Cells experience plasma membrane stress failure
when the matrix to which they adhere undergoes large
deformations (Vlahakis and Hubmayr 2005). There are
some adaptive responses of the lipid surface to deforming
stress in alveolar epithelial cells:
1) the cell might unfold plasma membrane, thus pre-
venting any increase in plasma membrane tension,
2) once unfolded, the plasma membrane stretches,
3) if these responses are overwhelmed, the plasma
membrane might either undergo stress failure or
further adapt its stress-bearing elements to prevent
plasma membrane breaks (Fig. 5) (McNeil and
Steinhardt 1997, Akinlaja and Sachs 1998, Liu et
al. 1999, Tschumperlin et al. 2000).
Lipid trafﬁcking to the cell surface is another adaptive
mechanism in alveolar epithelial cells (Vlahakis et al.
2001) (Fig. 5). Several observations on normal and in-
jured lungs raise interest in the molecule and pathway
speciﬁcity of deformation triggered vesicular trafﬁcking.
When lungs suffer relatively mild forms of interstitial
pulmonary edema, the lipid microdomains of lung cell
surface membranes undergo a substantial reorganization
(Palestini et al. 2003). The functional consequence of
membrane remodeling, which is almost certainly accom-
panied by changes in surface protein expression, remains
to be explored. In vitro, such changes are associated with
changes in cell phenotype and by inference, changes in
the cells susceptibility to mechanical injury. In endothe-
lial cells, ﬁbroblasts, and some epithelial cells, sphin-
golipids, cholesterol, and glycosylphosphatidylinisotol-
anchored proteins appear to have a preferential associ-
ation with 50- to 100-nm pits called caveolae (Razani
et al. 2002) (Fig. 5). These structures play an impor-
tant role in endocytosis processes and can be identiﬁed
in type I alveolar epithelium cells (Gil 1983, Kasper et
al. 1998). Caveolae are plasma membrane invaginations
that may unfold when laterally stressed, and may be
important not only for the mechanotransduction of de-
formation-induced lipid trafﬁcking, but also central for
the maintenance of sublytic membrane tension.
The biochemical and biophysical changes in plas-
ma membranes were also related to the changes in phys-
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Fig. 4 – Changes in extracellular matrix during hydraulic and lesional edemas. Pi: interstitial pressure,
W/D: wet-to-dry weight ratio, HS: Heparan sulfate, PG: Proteoglycan, CS: Chondroitin sulfate. MMP:
Matrix Metalloproteasis. During hydraulic edema the prevalent lesion is the fragmentation of the CS,
whilst in the lesional edema HS is damaged.
ical stimuli on endothelial cell surface. The increase in
tissue forces at interstitial level is a consequence of in-
terstitial ﬂuid accumulation, particularly in the air-blood
barrier as demonstrated by the increased thickness of
the extracellular matrix. Interstitial edema causes a raise
in interstitial ﬂuid pressure from the physiological value
of approximately –10 cmH2O up to ∼ 5 cmH2O (Mise-
rocchi et al. 1993, 2001a). As capillary pressure remains
essentially unchanged at∼10 cmH2O in mild interstitial
edema (Negrini 1995), the above condition should cause
a substantial alteration in the transmural pressure. In fact,
in physiological conditions, the transmural pressure is
relatively high, averaging 20 cmH2O, with the subatmo-
spheric interstitial pressure pulling the basal side of the
cell. Conversely, in edema the transmural pressure gra-
dient is reduced to 5 cmH2O, and the positive interstitial
pressure pushes the basal side of the cell. Furthermore,
parenchymal forces exerted at focal points where cell-
matrix attachments occur are expected to increase as a
consequence of swelling of the extracellular matrix.
Daffara and colleagues hypothesize a speciﬁc “sens-
ing” function by lung cells resulting from a perturbation
in cell-matrix interaction (Daffara et al. 2004). In this
context, the cell-matrix interaction may differ according
to the type of edema since differences were found in the
sequential degradation of PGs family and in the interac-
tion properties of PGs to some matrix components (Mis-
erocchi et al. 2001a). Based on these considerations,
Botto and coworkers described a differential response
of lung endothelial cells to hydraulic and hypoxic pul-
monary edema, inducing a speciﬁc cascade of cellular
events from signaling-transduction to cellular functional
attitude aimed at tissue repair (Botto et al. 2006).
CONCLUSIONS
ECM components such as the chondroitin sulfate (ver-
sican) and the heparan sulfate (perlecan) proteoglycans
play a major role in the maintenance of tissue ﬂuid
homeostasis providing: a) a highly restrictive perivas-
An Acad Bras Cienc (2007) 79 (2)
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Fig. 5 – Extracellular matrix (ECM) and cell response to increased lung interstitial pressure. Springs
represent ECM components. Arrowheads: the intensity of interstitial pressure. Arrows: the intensity of
stress on endothelium and epithelium. A: Normal pressure in the interstitium with no cell stress or ECM
lesion. Panel B: Increased pressure in the interstitium, with limited cell stress since the ECM is intact. Panel
C: During interstitial pressure increase, some components of ECMare ruptured, plasmamembrane unfolded
and stretched. Panel D: Adaptative cell response: the translocation of lipids from intracellular stores to
the plasma membrane (dashed square). Note the presence of caveolae (c) in endothelial and epithelial
cells. Panel E: Even though cells sensed the stress early, with further increase in interstitial pressure, pro-
inﬂammatory and ﬁbrogenic mediators were released. Panel F: Maintenance of increased stress associated
with the effects of pro-inﬂammatory andﬁbrogenicmediators contribute to the fragmentation of extracellular
matrix components and epithelial and endothelial cell rupture resulting in edema.
cular and interstitial sieve in relation to plasma proteins,
thus modulating both interstitial protein concentration
and trans-endothelialﬂuidﬁltration; b) amechanical sup-
port to lymphatic vessels sustaining andmodulating their
draining function, and c) a rigid three dimension low
compliant scaffold opposing ﬂuid accumulation into in-
terstitial space. Fragmentation of proteoglycans induced
by different stimuli such as: ﬂuid overload, exposure to
proteolytic or inﬂammatory agents, hypoxic or hyper-
oxic gas mixtures, or increased tissue strain/stress, result
in a progressive loosening of proteoglycans intermolec-
ular connections with other ECM components. The loss
of the proteoglycans regulatory functions compromises
the protective role of the ECM, leading to interstitial and
eventually severe lung edema. Thus, once conditions of
increased microvascular ﬁltration are established, matrix
remodeling proceeds fairly rapidly due to the activation
of proteases. Interestingly enough in experimentally in-
duced ﬁbrosis a massive matrix deposition would be ex-
pected to decrease interstitial compliance and therefore
make the tissue safety factor stronger. This possible de-
fense against alveolar ﬂooding does not seem to oper-
ate, so far. However, it seems that the extensive matrix
remodeling led to a decreased hydraulic resistance of
An Acad Bras Cienc (2007) 79 (2)
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both the endothelial and the epithelial barrier and pos-
sibly of the interstitial matrix.
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RESUMO
A matriz extracelular é um aglomerado tridimensional de
macromoléculas composta por: ﬁbras colágenas (principal-
mente, tipos I e III), elastina, glicosaminoglicanos e proteogli-
canos. No pulmão, a matriz extracelular tem várias funções,
tais como: 1) promover estresse tensil e elasticidade tecidual,
2) contribuir para a manutenção da dinâmica de ﬂuidos no
interstício, 3) propiciar efetiva troca gasosa, 4) controlar a
função celular através de sua ligação com fatores de cresci-
mento, quimiocinas, citocinas e interação com receptores de su-
perfície, e 5) remodelamento e reparo tecidual. A fragmentação
e a desorganização da matriz extracelular pode acarretar edema
intersticial e, eventualmente, edema alveolar grave. Logo,
quando há aumento da ﬁltração microvascular ocorre rápido
remodelamento da matriz por ativação de proteases. Destarte,
a deposição de ﬁbras colágenas reduz a complacência intersti-
cial limitando o edema. Em conclusão, modiﬁcações na matriz
extracelular podem afetar a formação e distribuição do edema
no pulmão.
Palavras-chave: colágeno, glicosaminoglicanos, proteoglica-
nos, pressão intersticial.
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